Startups
EVER Pharma
Unterach, Austria · Jena, Germany
EVER Pharma is a privately owned specialty pharmaceutical group headquartered in Unterach, Austria, focused on neurology and complex sterile injectables for oncology, intensive care and hormone therapy. The group traces its origins to EBEWE Pharma, founded in Vienna in 1934; the neurology business was spun off and rebranded EVER Pharma in 2008–2009 when the oncology business was sold to Novartis. Its facilities in Austria and Germany develop and manufacture injectable medicines and drug-delivery devices. Its neurological product portfolio includes Cerebrolysin and Dacepton, alongside D-mine pen and infusion-pump devices for Parkinson’s disease medication delivery; indications and availability depend on the local market. Its published group management includes chairman and owner Friedrich Hillebrand, CEO Georges Kahwati, and managing director and co-owner Julia Hillebrand. The website identifies EVER Neuro Pharma GmbH and EVER Pharma Jena GmbH as operating entities. Although nyra health financing announcements use the EVER Pharma brand, its registered shareholder and historical investment vehicle is the separate Hillebrand family-office entity HIL-INVENT Ges.m.b.H.; those equity participations must not be attributed to the operating pharmaceutical group. Published R&D spending and manufacturing investments are operational expenditure rather than venture financing rounds.
Founded 1934
Team
 Friedrich HillebrandChairman and Owner |
 Georges KahwatiChief Executive Officer |
 Julia HillebrandManaging Director and Co-owner |
Investments
No investment rounds on record yet.